Hong Seng's unit signs collaborative agreement with Mediven

Hong Seng executive director and HS Bio director Christopher Chan

KUALA LUMPUR: Hong Seng Consolidated Bhd’s healthcare arm HS Bio Sdn Bhd has signed a collaboration agreement with Mediven Innovation Ventures Sdn Bhd to expand their respective coverage in the healthcare sector.

Mediven is a group of companies involved in the healthcare sector and has approvals, licences accreditations